35418-07-6

Basic information

• Product Name: Methyl 3-(4-aMinophenyl)propionate
• Synonyms: Methyl 3-(4-aMinophenyl)propionate;Methyl 3-(4-aminophenyl)
• CAS NO: 35418-07-6
• Molecular Formula: C₁₀H₁₃NO₂
• Molecular Weight: 179.21572
• Mol File: 35418-07-6.mol
• Article Data: 37

Chemical Properties

• Appearance: /
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• CAS DataBase Reference: Methyl 3-(4-aMinophenyl)propionate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 3-(4-aMinophenyl)propionate(35418-07-6)
• EPA Substance Registry System: Methyl 3-(4-aMinophenyl)propionate(35418-07-6)

Safety Data

• Hazardous Substances Data: 35418-07-6(Hazardous Substances Data)

Usage

General Description

Methyl 3-(4-aminophenyl)propionate is an organic compound that belongs to the family of aromatic compounds. It is derived from the amino acid phenylalanine and is commonly used in the pharmaceutical industry as a precursor for the synthesis of various drugs and pharmaceuticals. Methyl 3-(4-aMinophenyl)propionate has a molecular formula of C11H15NO2 and a molecular weight of 193.24 g/mol. It is a white to off-white crystalline powder that is soluble in organic solvents such as ethanol and acetone. Methyl 3-(4-aminophenyl)propionate is known for its analgesic and anti-inflammatory properties, making it a valuable component in the production of pain relief medications. However, it should be handled with caution and proper safety measures, as it may cause skin and eye irritation.

Upstream product

• 637-57-0 methyl 4-nitrocinnamate 
• 54405-42-4 methyl 3-(4-nitrophenyl)propanoate 
• 318510-90-6 methyl 3-(4-((tert-butoxycarbonyl)amino)phenyl)propanoate 
• 540-37-4 p-aminoiodobenzene 
• 224635-57-8 ⁽³⁾-[4-(tert-Butoxycarbonylamino)phenyl]-propenoic acid methyl ester 
• 159217-89-7 N-Boc-4-iodoaniline 
• 292638-85-8 acrylic acid methyl ester 
• 586-78-7 para-nitrophenyl bromide 
• 100-00-5 4-chlorobenzonitrile 
• 619-89-6 p-nitrocinnamic acid 
• 501-52-0 3-Phenylpropionic acid 
• 16642-79-8 3-(4-nitrophenyl)propionic acid 
• 882-06-4 4-nitro-trans-cinnamic acid 
• 637-57-0 p-nitrocinnamic acid methyl ester 

Downstream Products

• 391610-79-0 3-(4-[N_α-tert-butoxycarbonyl-L-leucinoylamino]phenyl)propanoic acid methyl ester 
• 1026819-81-7 3-[4-(2-propyl-pentanoylamino)-phenyl]-propionic acid methyl ester 
• 525589-19-9 methyl 3-(4-(phenylamino)phenyl)propanoate 
• 945414-29-9 methyl 3-(4-(tert-butoxycarbonyl(phenyl)amino)phenyl)propanoate 
• 945414-30-2 3-(4-(tert-butoxycarbonyl(phenyl)amino)phenyl)propanoic acid 
• 945414-31-3 tert-butyl 4-(3-oxo-3-(5-(pyridin-2-yl)oxazol-2-yl)propyl)phenyl(phenyl)carbamate 
• 415911-39-6 3-{4-[(4,6-Dimethyl-3-nitro-2-pyridinyl)amino]phenyl}propanoic Acid 
• 1057107-48-8 C₁₈H₁₇F₃N₂O₃ 
• 1210908-75-0 (E)-methyl 3-(4-(5,5,5-trifluoro-4-oxopent-2-en-2-ylamino)phenyl)propanoate 
• 61629-76-3 β-[4-(5-chloro-2-methoxybenzamido)-phenyl]-propionic acid 
• 75567-86-1 3-(4-dimethylaminophenyl)propionic acid methyl ester 
• 117625-36-2 (15S)-17-(4-azido-3-iodophenyl)-18,19,20-trinorprostaglandin F_2α 
• 117706-85-1 (E)-7-[(1R,2R,3R,5S)-2-[(E)-(S)-5-(4-Azido-3-iodo-phenyl)-3-(tert-butyl-dimethyl-silanyloxy)-pent-1-enyl]-3,5-bis-(tert-butyl-dimethyl-silanyloxy)-cyclopentyl]-hept-5-enoic acid methyl ester 
• 117625-34-0 (15S)-17-(4-azido-3-iodophenyl)-18,19,20-trinorprostaglandin F_2α methyl ester 9,11,15-tris(tert-butyldimethylsilyl ether) 

Relevant articles and documents

A convenient method for the synthesis of Troger's base analogues

Para substituted anilines have been converted to Troger's base analogues by refluxing with a mixture of methylal and methanesulfonic acid.

IN VITRO METHOD FOR DETECTION OF INFECTIONS CAUSED BY PSEUDOMONAS AERUGINOSA

In vitro method for detection of infections caused by pseudomonas aeruginosa. The present invention relates to compounds of general Formula (I) and to their use as haptens. Moreover, the present invention also refers to conjugates comprising the haptens of the invention and to their use for obtaining antibodies. Finally, the invention also relates to an in vitro method for the detection of infections caused by Pseudomonas aeruginosa by means of the identification and/or quantification of the main signaling molecules from the pqs quorum sensing system.

(PYRIDIN-2-YL)AMINE DERIVATIVES AS TGF-BETA R1 (ALK5) INHIBITORS FOR THE TREATMENT OF CANCER

The present invention relates to pharmaceutical compounds, compositions and methods, especially as they are related to compositions and methods for the treatment and/or prevention of a proliferation disorder associated with ΤGFβR1 activity, such as a cancer or fibrosis. The invention provides compounds of Formula (I) and Formula (II) as further described herein having an acidic moiety that enhances tissue specificity for targeted tissues and organs. The invention includes pharmaceutical compositions, pharmaceutical combinations, and methods of use of these compounds for treating conditions including cancer or fibrosis.